HeavenlyDoor.com, Inc. is a publicly traded Internet
company whose objectives are to provide products and
services for the elderly and aging baby boomer population,
with an initial focus on the pre-planning of funerals, and
ultimately the long-term care, assisted living and
financial/estate planning industries. The company, through
its subsidiary d/b/a Procept, Inc., has licensed its
biotechnology compound, PRO 2000 Gel to Interneuron
Pharmaceuticals, Inc. (NASDAQ: IPIC - news) on June 15,
2000 and seeks to license its biotechnology compound,
O6-Benzylguanine. Both of these biotechnology
compounds have had substantial government support for
their clinical trials to date.